Approximately 40 million people or one in four households includes someone with migraine disease, and 85% of people with the disease are women. Despite the prevalence of the disease, lack of education and awareness often
Many people like to include devices in their treatment plans because they are non-invasive and have low side-effect profiles. In this week’s episode of Heads Up, Dr. Tim Smith and Dr. Lindsay Weitzel discuss
New data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness in Episode 69 of Heads UP.